Clinical trial
Clinical Study of KW-2246 in Patients With Cancer Pain
NCT00355628 · Kyowa Kirin Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00355628 |
|---|---|
| Title | Clinical Study of KW-2246 in Patients With Cancer Pain |
| Official title | Phase II Clinical Study of KW-2246 in Patients With Cancer Pain - Maintenance Switch Study in Oral Morphine or Oral Oxycodone-treated Patients |
| Lead sponsor | Kyowa Kirin Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pain, Cancer |
| Intervention type | Drug |
| Interventions | KW-2246 (fentanyl citrate) |
| Enrollment | 40 |
| Start date | Jul 1, 2006 |
| Primary completion | Jul 1, 2007 |
| First posted | Jul 24, 2006 |
| Last update posted | Aug 31, 2012 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: